Hi Eddie,
Totally understand the connection between COVID-19 & DMX-700, a few of us were wondering about that before the ANN came out & the pulmonary connection there, but that is still in pre-clinical, so it kind of didn’t make sense in a PH4 trial. DMX-200 does on the new RAAS arm, and reflecting on comments from Dimerix, that we are in a unique position here, I’m just wondering when this protocol is published on REMAP-CAP website, will DMX-200 + ARB possibly be the only drug at this point in time?
It’s still an IND so that in itself to convince the International REMAP-CAP medical advisory board to include DMX-200 on the trial is pretty special, there would have to be very compelling evidence. I did bring my laptop home from work this weekend so will do some searches on CIAP & share here.
- Forums
- ASX - By Stock
- Ann: Positive Top-Line Results in DKD Phase 2 Clinical Study
Hi Eddie,Totally understand the connection between COVID-19 &...
-
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
|
|||||
Last
45.0¢ |
Change
0.015(3.45%) |
Mkt cap ! $247.7M |
Open | High | Low | Value | Volume |
44.0¢ | 46.5¢ | 42.5¢ | $1.090M | 2.454M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 63703 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 35469 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 63703 | 0.450 |
4 | 86106 | 0.445 |
2 | 34093 | 0.440 |
3 | 86821 | 0.435 |
6 | 147222 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 35469 | 2 |
0.465 | 61821 | 2 |
0.470 | 115603 | 5 |
0.475 | 344321 | 6 |
0.480 | 71700 | 2 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online